Tear Ferning Test for Dry Eye Diagnosis
Application of Tear Ferning Test for Clinical Dry Eye Diagnosis
1 other identifier
interventional
26
1 country
1
Brief Summary
Application of tear ferning test for clinical dry eye diagnosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 2024
CompletedFirst Submitted
Initial submission to the registry
April 8, 2024
CompletedFirst Posted
Study publicly available on registry
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2024
CompletedAugust 29, 2025
August 1, 2025
2 months
April 8, 2024
August 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Schirmer's test
to assess tear secretion volume
5 minutes
Tear film breakup time
to assess tear quality
20 seconds
Ocular surface health evaluate
To assess the health status with Lissamine green stain
3 minutes
Secondary Outcomes (2)
Ocular surface disease index
20 minutes
Intraocular pressure
2 minutes
Study Arms (2)
Dry eye patients
NO INTERVENTIONCollect clinical information and tear samples from patients with dry eye syndrome.
Non-Dry eye patients
OTHERCollect clinical information and tear samples from patients without dry eye syndrome.
Interventions
compare tear ferning structure between dry eye and non-dry eye patients
Eligibility Criteria
You may qualify if:
- Aged between 20 and 65 years
- For dry eye disease group:
- Schirmer's test results between 5 - 10 mm
- Tear Film Break Up Time less than 10 seconds
- Ocular Surface Disease Index of more than 25
You may not qualify if:
- Those have diabetes, hypertension or other chronic diseases
- No evident ocular diseases such as cornea disease, cataracts, vitreous degeneration, glaucoma, and retinopathy.
- Belong to vulnerable groups(pregnancy woman, prisoner, ethical minorities, economic or educationally disadvantaged subjects, disabled individuals such as those at terminal stage of tumorigenesis, blindness, terminal ill individuals)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jen-Ai Hospital
Taichung, 412, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chung Shan Medical University
Study Record Dates
First Submitted
April 8, 2024
First Posted
April 15, 2024
Study Start
April 5, 2024
Primary Completion
May 22, 2024
Study Completion
May 22, 2024
Last Updated
August 29, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share